levodopa has been researched along with naloxone in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (56.14) | 18.7374 |
| 1990's | 8 (14.04) | 18.2507 |
| 2000's | 8 (14.04) | 29.6817 |
| 2010's | 6 (10.53) | 24.3611 |
| 2020's | 3 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hosoya, E; Oka, T | 1 |
| Eidelberg, E; Erspamer, R | 1 |
| Borison, RL; Diamond, BI | 1 |
| Jacob, JJ; Ramabadran, K | 1 |
| Agnati, LF; Benfenati, F; Capelli, M; Cortelli, P; D'Alessandro, R; Galassi, E | 1 |
| Chrétien, M; Motomatsu, T; Seidah, N | 1 |
| Bhargava, HN | 1 |
| Blum, K; Hirst, M; Marshall, A | 1 |
| Buckett, WR; Shaw, JS | 1 |
| Sparber, SB; Takemori, AE; Tulunay, FC | 1 |
| Moroz, LI; Winlow, W | 1 |
| Kim, HS; Kim, SH; Oh, KW; Rheu, HM | 1 |
| Holman, RB; Widdowson, PS | 1 |
| Carey, RJ | 1 |
| Persson, B; Rubenson, A; Sillén, U | 1 |
| Rubenson, A; Sillén, U | 1 |
| Dill, RE; Dorris, RL; Miller, EG; Sanders, R | 1 |
| Dluzen, DE; McDermott, JL; Ramirez, VD | 1 |
| Lucas, TS; Quock, RM | 2 |
| Bhattacharya, SK; Parmar, SS | 1 |
| Sandyk, R; Snider, SR | 1 |
| Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 2 |
| Barnes, RB; Lobo, RA | 1 |
| Chiu, S; Mishra, RK | 1 |
| Gonzalez, JP; Littler, ME; Sewell, RD | 1 |
| Molitch, ME; Spiler, IJ | 1 |
| Blass, R; Feigenbaum, J; Yanai, J | 1 |
| Johnson, C; Mitchell, J; Stuckey, M | 1 |
| Koskinen, V; Laakso, K; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK; Tenovuo, O | 1 |
| Bannister, R; Forsling, M; Lightman, SL; Puritz, R; Wilcox, CS | 1 |
| Lightman, SL | 1 |
| Bassi, S; Frattola, L; Trabucchi, M | 1 |
| Malone, MH; Namba, MM; Quock, RM | 2 |
| Caffarra, P; Chiodera, P; Coiro, V; Maestri, D; Scaglioni, A; Volpi, R | 1 |
| Brotchie, JM; Henry, B | 1 |
| el-Kadi, AO; Sharif, SI | 1 |
| Schomburg, ED; Steffens, H | 1 |
| Andrén, PE; Gunne, L; Klintenberg, R; Svenningsson, P | 1 |
| Bédard, PJ; Grégoire, L; Samadi, P | 1 |
| Brotchie, J; Crossman, A; Davies, R; Fletcher, N; Fox, S; Kellett, M; Silverdale, M; Steiger, M | 1 |
| Chen, L; Di Monte, DA; Langston, JW; Quik, M; Togasaki, DM | 1 |
| Benabid, AL; Berger, F; Buggia, V; Gilbert, F; Lévesque, D; Sgambato-Faure, V | 1 |
| Frohnhofen, H; Schlitzer, J | 1 |
| Bruno, V; Farcy, N; Karnik, V; Zamorano, C | 1 |
| Belfiore, G; Contrafatto, D; Mostile, G; Nicoletti, A; Terranova, R; Zappia, M | 1 |
| Castro, JC; Dalle, CR; Domingues-Hajj, PMS; Grandi-Miranda, FT; Milhomem, CBSS; Morais, BA; Reis, DM; Santos, UM; Silva, DJ; Souza, JT; Vilela-Filho, O | 1 |
3 review(s) available for levodopa and naloxone
| Article | Year |
|---|---|
Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis.
Topics: Adrenocorticotropic Hormone; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Chlorpromazine; Cyproheptadine; Dopamine; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Levodopa; Lithium; Lithium Carbonate; Male; Naloxone; Phenytoin; Pimozide; Serotonin; Zinc | 1983 |
[Sleep and sleep disorders in the elderly: Part 3: Restless legs syndrome].
Topics: Aged; Anemia, Iron-Deficiency; Cross-Sectional Studies; Dopamine Agonists; Drug Combinations; Female; Germany; Humans; Levodopa; Male; Naloxone; Oxycodone; Restless Legs Syndrome; Risk Factors; Sex Factors | 2015 |
Current Status of Pain Management in Parkinson's Disease.
Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2020 |
2 trial(s) available for levodopa and naloxone
| Article | Year |
|---|---|
Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease.
Topics: Adrenocorticotropic Hormone; Humans; Levodopa; Luteinizing Hormone; Male; Middle Aged; Naloxone; Parkinson Disease | 1994 |
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Naloxone; Narcotic Antagonists; Parkinson Disease; Videotape Recording | 2004 |
52 other study(ies) available for levodopa and naloxone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Fenclonine; Levodopa; Male; Methyltyrosines; Morphine; Motor Activity; Naloxone; Neurotransmitter Agents; Rats; Scopolamine | 1976 |
Dopaminergic mechanisms of opiate actions in brain.
Topics: Analgesics; Animals; Brain; Dopamine; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Levodopa; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Reaction Time; Synapses; Synaptic Transmission | 1975 |
Enkephalins and nigrostriatal function.
Topics: Animals; Apomorphine; Behavior, Animal; Dextroamphetamine; Endorphins; Enkephalins; Hydroxydopamines; Levodopa; Male; Naloxone; Parkinson Disease; Parkinson Disease, Secondary; Phenethylamines; Rats; Receptors, Opioid; Reserpine; Substantia Nigra | 1978 |
Facilitatory effect of naloxone and involvement of specific ligand-opiate receptor system in the antinociceptive effects of non-opioid drugs.
Topics: Analgesics; Animals; Baclofen; Benperidol; Haloperidol; Levodopa; Male; Mice; Naloxone; Phosphodiesterase Inhibitors; Pimozide; Receptors, Opioid; Sympathomimetics | 1978 |
Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man.
Topics: Adult; Bromocriptine; Drug Synergism; Feedback; Growth Hormone; Humans; Levodopa; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1979 |
Cataleptic effect of 61-91 beta-lipotropic hormone in rat.
Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Drug; Humans; Levodopa; Naloxone; Rats; Sheep; Tremor | 1977 |
Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
Topics: Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Humans; Levodopa; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Substance Withdrawal Syndrome | 1978 |
Analgesic effects of 3-carboxysalsolinol alone and in combination with morphine.
Topics: Analgesia; Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Isoquinolines; Levodopa; Mice; Morphine; Naloxone; Salsoline Alkaloids | 1977 |
Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benztropine; Cyclazocine; Dopamine; Dose-Response Relationship, Drug; Humans; Levallorphan; Levodopa; Male; Motor Activity; Naloxone; Piribedil; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1975 |
The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
Topics: Analgesics; Animals; Apomorphine; Depression, Chemical; Dopamine; Haloperidol; Levodopa; Male; Mice; Morphine; Naloxone; Pain; Pimozide; Reaction Time; Receptors, Drug; Stimulation, Chemical | 1975 |
Respiratory behaviour in Lymnaea stagnalis: pharmacological and cellular analyses.
Topics: Animals; Behavior, Animal; Dopamine; Levodopa; Lymnaea; Naloxone; Nerve Net; Neurotransmitter Agents; Respiration; Respiratory System; Serotonin | 1992 |
Antagonism of U-50,488H-induced antinociception by ginseng total saponins is dependent on serotonergic mechanisms.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Dihydroxyphenylalanine; Levodopa; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Panax; Plants, Medicinal; Pyrrolidines; Reaction Time; Saponins; Serotonin | 1992 |
Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates.
Topics: Animals; beta-Endorphin; Dopamine; Endorphins; Enkephalin, Leucine; Ethanol; Levodopa; Male; Naloxone; Narcotic Antagonists; Potassium; Rats; Rats, Inbred Strains | 1992 |
Naloxone reverses L-dopa induced overstimulation effects in a Parkinson's disease animal model analogue.
Topics: Animals; Carbidopa; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Hydroxydopamines; Levodopa; Male; Mesencephalon; Naloxone; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Baclofen; Bicuculline; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Injections, Intraventricular; Levodopa; Male; Naloxone; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder | 1985 |
Central and peripheral motor effects of morphine on the rat urinary bladder.
Topics: Acetylcholine; Animals; Carbidopa; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intra-Arterial; Injections, Intraventricular; Levodopa; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Pelvis; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder | 1986 |
Analgesic effects of 3-methoxybenzamide in rats.
Topics: Analgesics; Animals; Behavior, Animal; Benzamides; Levodopa; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Time Factors | 1989 |
The effect of L-dopa upon in vitro dopamine release from the corpus striatum of young and old male rats.
Topics: Aging; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Levodopa; Male; Naloxone; Rats; Rats, Inbred Strains | 1989 |
A selective potentiation by naloxone of L-dopa but not atropine suppression of oxotremorine-induced tremor in mice.
Topics: Animals; Atropine; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Time Factors; Tremor | 1985 |
Stress by restraining potentiates morphine catalepsy in rats.
Topics: 5,6-Dihydroxytryptamine; Animals; Benserazide; Catalepsy; Diclofenac; Ditiocarb; Drug Interactions; Fenclonine; Hemicholinium 3; Levodopa; Male; Mefenamic Acid; Morphine; Naloxone; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological | 1985 |
Naloxone treatment of L-dopa-induced dyskinesias in Parkinson's disease.
Topics: Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Naloxone; Parkinson Disease; Receptors, Opioid | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.
Topics: Adult; Brain Chemistry; Carbidopa; Dopamine; Endorphins; Estrogens; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Naloxone; Polycystic Ovary Syndrome; Prolactin | 1985 |
Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Humans; Levodopa; Lysergic Acid Diethylamide; Male; MSH Release-Inhibiting Hormone; Naloxone; Parasympathomimetics; Rats; Synaptic Transmission; Time Factors | 1980 |
Stereoselective opiate antagonist induced hyperalgesia: evidence for a dopaminergic involvement.
Topics: Animals; Apomorphine; Dopamine; Injections, Intraventricular; Levodopa; Male; Mice; Naloxone; Narcotic Antagonists; Nomifensine; Pain; Tetrabenazine | 1982 |
Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.
Topics: Female; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Levodopa; Male; Naloxone; Neural Pathways; Physical Exertion; Pituitary Hormones; Prolactin; Receptors, Opioid; Stress, Physiological | 1980 |
Possible DA agonist properties of naloxone.
Topics: Animals; Brain; Dextroamphetamine; Humans; Hydroxybutyrates; Levodopa; Mice; Motor Activity; Naloxone; Rats; Receptors, Dopamine; Receptors, Opioid; Stereotyped Behavior | 1982 |
Brain enkephalin receptors in Parkinson's disease.
Topics: Aged; Brain; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Female; Humans; Kinetics; Levodopa; Male; Naloxone; Nucleus Accumbens; Parkinson Disease; Receptors, Dopamine; Receptors, Opioid; Substantia Nigra | 1983 |
Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats.
Topics: Animals; Bromocriptine; Central Nervous System Agents; Corpus Striatum; Levodopa; Naloxone; Nervous System; Rats | 1984 |
Potentiation by naloxone of the anti-oxotremorine effect of L-DOPA.
Topics: Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Tremor | 1983 |
Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone.
Topics: Aged; Arginine Vasopressin; Autonomic Nervous System Diseases; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Naloxone; Physical Stimulation; Posture | 1983 |
Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
Topics: Adult; Aldosterone; Carbidopa; Domperidone; Dopamine; Female; Humans; Hydrocortisone; Levodopa; Male; Naloxone; Posture; Renin | 1981 |
Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy.
Topics: Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Naloxone; Parkinson Disease; Receptors, Dopamine | 1982 |
Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy.
Topics: Animals; Catalepsy; Drug Synergism; Humans; Levodopa; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Reserpine; Time Factors | 1980 |
Effects of narcotic antagonists on L-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice.
Topics: Animals; Blepharoptosis; Catalepsy; Drug Antagonism; Drug Synergism; Humans; Kinetics; Levodopa; Male; Mice; Naloxone; Naltrexone; Reserpine | 1981 |
Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Naloxone; Narcotic Antagonists; Parkinson Disease | 1996 |
The role of dopamine in the expression of morphine withdrawal.
Topics: Adrenergic Agents; Analgesia; Analgesics, Opioid; Analysis of Variance; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Antagonists; Hypothermia; Levodopa; Male; Mice; Morphine; Naloxone; Narcotic Antagonists; Oxidopamine; Substance Withdrawal Syndrome | 1998 |
Comparative analysis of L-DOPA actions on nociceptive and non-nociceptive spinal reflex pathways in the cat.
Topics: Animals; Cats; Conditioning, Psychological; Dopamine; Dose-Response Relationship, Drug; Hot Temperature; Levodopa; Naloxone; Narcotic Antagonists; Neural Inhibition; Neurons, Afferent; Nociceptors; Reflex; Spinal Cord | 1998 |
Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benserazide; Callithrix; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Enkephalins; Female; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Narcotic Antagonists; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; RNA; Rotation; Stereotyped Behavior; Sympathectomy, Chemical | 2002 |
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Dopamine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Endorphins; Female; Levodopa; Macaca fascicularis; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 2003 |
Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
Topics: Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Naloxone; Narcotic Antagonists; Narcotics; Nerve Tissue Proteins; Parkinsonian Disorders; Protein Binding; Receptors, Opioid; Saimiri; Sulfur Isotopes | 2005 |
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agents; AIDS-Related Complex; Amphetamine; Analgesics, Non-Narcotic; Animals; Antiparkinson Agents; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dynorphins; Dyskinesia, Drug-Induced; Functional Laterality; Homer Scaffolding Proteins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxidopamine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
Acute motor effects induced by opioid antagonists in Parkinson's disease: could naloxone be a rescue therapy?
Topics: Analgesics, Opioid; Humans; Levodopa; Naloxone; Narcotic Antagonists; Parkinson Disease | 2021 |
Induction of Ticlike Involuntary Movements in Rats by Striatotomy and Subsequent Neurochemical Sensitization.
Topics: Analgesics, Non-Narcotic; Animals; Benserazide; Corpus Striatum; Dopamine Agents; Double-Blind Method; Drug Combinations; Ergotamine; Female; Globus Pallidus; Levodopa; Naloxone; Prospective Studies; Rats; Rats, Wistar; Stereotaxic Techniques; Tourette Syndrome | 2021 |